MajesTEC-7
A Study to Compare Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) in Participants With Newly Diagnosed Multiple Myeloma (MajesTEC-7)
Filters
Save & Share
Clear Filters
Location
Explore options near your patient - or anywhere in the US.
Diagnosis
Treatment History
BCMA Therapy
This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel or belantamab mafodotin.
Near Add Your Location
Sorting 21 by
- Not yet accepting
Tufts Medical Center Cancer Center
Boston, MA
- Not yet accepting
Boston Medical Center
Boston, MA
- Not yet accepting
Henry Ford Hospital
Detroit, MI
- Not yet accepting
Ascension Providence Cancer Center (Foster Winter Drive)
Southfield, MI
- Not yet accepting
- Not yet accepting
- Not yet accepting
Durham Veterans Affairs Medical Center
Durham, NC
- Not yet accepting
- Not yet accepting
Lehigh Valley Health Network Cancer Institute
Allentown, PA
- Not yet accepting
1,353 hidden based on your filters. Show All
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.